Rupitha, N. S. published the artcileEvaluation of fibrates for anticancer activity – an insilico approach, Quality Control of 637-07-0, the publication is Journal of Pharmaceutical Sciences and Research (2020), 12(9), 1198-1200, database is CAplus.
Cancer is a major cause of death throughout the world, and cancer therapy remains a big medical challenge in terms of both its therapeutic efficacy and safety. Therefore, to find out safe anticancer drugs has been major goal for medical scientists. Fibrates class of drugs plays an important role in decreasing the levels of serum cholesterol and triglycerides while increasing the levels of high-d. lipoproteins. Recently, several studies have reveals that fibrates may also have anticancer effects via a variety of pathways involved in apoptosis, cell-cycle arrest, invasion, and migration. Insilico approaches have been applied to evaluate the potential interaction between the target and the fibrate derivatives
Journal of Pharmaceutical Sciences and Research published new progress about 637-07-0. 637-07-0 belongs to chlorides-buliding-blocks, auxiliary class Inhibitor,Cell Cycle,PPAR, name is Ethyl 2-(4-chlorophenoxy)-2-methylpropanoate, and the molecular formula is C12H15ClO3, Quality Control of 637-07-0.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics